January 17, 2018 | Jennifer Mattson
In the summer of 2015, Mollie Warner was living a happy, active life in Rancho Cucamonga, California, with her husband. She worked out regularly at the gym, lifted weights and was even taking a kickboxing class when she started feeling fatigued.
Behnam Ebrahimi, M.D.: Leading-edge Care in Rancho Cucamonga
March 19, 2018 | Travis Marshall
As a medical oncologist at City of Hope’s Rancho Cucamonga location, Behnam Ebrahimi, M.D., treats a wide range of cancer types, and enjoys being part of a center renowned for its multidisciplinary care.
City of Hope Researchers Find “Achilles' Heel” in B Cell Tumors
March 14, 2018 | Katie Neith
In a new paper published in the journal Cell, a team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., and Gang Xiao, Ph.D., reports on the discovery of a new therapeutic target for these B cell malignancies.
Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions
March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
Returning People Back to Normal: Meet Jonathan Warner, M.D.
March 9, 2018 | Travis Marshall
City of Hope’s Jonathan Warner, M.D., dedicates his time to improving quality of life for prostate cancer survivors, and he’s renowned for his use of advanced techniques in urologic reconstruction.
New Drug Appears Promising Against Chronic Myelogenous Leukemia
March 7, 2018 | Letisia Marquez
City of Hope researchers may have discovered a more effective treatment for patients with chronic myelogenous leukemia (CML) according to a study published today in Nature Medicine.
‘Goldilocks’ Therapies Could Be a Breakthrough for Patients with Lymphoma
March 6, 2018 | City of Hope
Thanks to research being done by City of Hope's Markus Müschen, M.D., Ph.D., lymphoma patients may soon receive treatments that leverage quality control mechanisms that our own immune systems utilize to fight harmful antibodies.
The Future of Diabetes Care: Islet Cell Transplantation for T1D
March 5, 2018 | Letisia Marquez
City of Hope's Fouad Kandeel, M.D., Ph.D., and an LA pediatrician and islet cell transplant recipient appeared on Sirius XM's Doctor Radio to discuss islet cell transplantation becoming the standard of care in the U.S.
Leukemia Drug Shows Promise Against Rare Ovarian Cancer
March 2, 2018 | City of Hope
City of Hope affiliate TGen has found that an anti-cancer drug used to fight leukemia shows promise against SCCOHT, a rare and aggressive type of ovarian cancer.
Facing Down Uncertainty: Meet Benjamin Djulbegovic, M.D., Ph.D.
March 1, 2018 | Wayne Lewis
The unknown can be scary. But according to City of Hope hematologist Benjamin Djulbegovic, M.D., Ph.D., it’s important to face uncertainty — at least enough to understand it.
Rick Kittles, Ph.D.: On a Mission to Eliminate Health Inequities
February 28, 2018 | Samantha Bonar
For City of Hope's Rick Kittles, Ph.D., exploring genes and environments to understand health disparities among different populations isn’t just a scientific pursuit — it is a passion driven by social justice concerns.